NeXeption

About:

NeXeption is a biopharmaceutical company bringing together expertise, management and funding for partnerships.

Top Investors: Third Point Ventures, New Science Ventures, Palo Alto Investors

Description:

NeXeption, LLC is a biopharmaceutical management company that brings together product opportunities, management expertise and the necessary funding to reach compelling partnership milestones. The NeXeption management team has a proven track record in raising capital, operating development stage companies and forming strategic partnerships to advance products for the benefit of patients.

Total Funding Amount:

$21.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Malvern, Pennsylvania, United States

Founded Date:

2011-05-01

Founders:

Kamil Ali-Jackson, Stephen Tullman

Number of Employees:

1-10

Last Funding Date:

2014-01-02

IPO Status:

Private

Industries: